Machine learning identifies biomarkers that predict a patien

Deep neural network framework, DeepGeneX, identifies genes that can accurately predict a patient’s response to immune-checkpoint therapy

Related Keywords

United States , American , Taran Gujral , Sid Vijay , Yuqi Kang , Gujral Lab , National Science Foundation , Human Biology Division , Columbia University , American Cancer Society , Associate Professor , Human Biology , Cancer Genome , For Alzheimer , American Cancer , Seattle Children , Cancer Consortium , Immunotherapy , Machine Learning , Biomarkers ,